37190913|t|Plasma and CSF concentrations of N-terminal tau fragments associate with in vivo neurofibrillary tangle burden.
37190913|a|INTRODUCTION: Fluid biomarkers capable of specifically tracking tau tangle pathology in vivo are greatly needed. METHODS: We measured cerebrospinal fluid (CSF) and plasma concentrations of N-terminal tau fragments (NTA-tau), using a novel immunoassay (NTA) in the TRIAD cohort, consisting of 272 individuals assessed with amyloid beta (Abeta) positron emission tomography (PET), tau PET, magnetic resonance imaging (MRI) and cognitive assessments. RESULTS: CSF and plasma NTA-tau concentrations were specifically increased in cognitively impaired Abeta-positive groups. CSF and plasma NTA-tau concentrations displayed stronger correlations with tau PET than with Abeta PET and MRI, both in global uptake and at the voxel level. Regression models demonstrated that both CSF and plasma NTA-tau are preferentially associated with tau pathology. Moreover, plasma NTA-tau was associated with longitudinal tau PET accumulation across the aging and Alzheimer's disease (AD) spectrum. DISCUSSION: NTA-tau is a biomarker closely associated with in vivo tau deposition in the AD continuum and has potential as a tau tangle biomarker in clinical settings and trials. HIGHLIGHTS: An assay for detecting N-terminal tau fragments (NTA-tau) in plasma and CSF was evaluated. NTA-tau is more closely associated with tau PET than amyloid PET or neurodegeneration. NTA-tau can successfully track in vivo tau deposition across the AD continuum. Plasma NTA-tau increased over time only in cognitively impaired amyloid-beta positive individuals.
37190913	81	103	neurofibrillary tangle	Disease	MESH:D055956
37190913	176	179	tau	Gene	4137
37190913	312	315	tau	Gene	4137
37190913	327	330	NTA	Chemical	MESH:D009571
37190913	331	334	tau	Gene	4137
37190913	364	367	NTA	Chemical	MESH:D009571
37190913	434	446	amyloid beta	Gene	351
37190913	448	453	Abeta	Gene	351
37190913	491	494	tau	Gene	4137
37190913	584	587	NTA	Chemical	MESH:D009571
37190913	588	591	tau	Gene	4137
37190913	650	658	impaired	Disease	MESH:D060825
37190913	659	664	Abeta	Gene	351
37190913	697	700	NTA	Chemical	MESH:D009571
37190913	701	704	tau	Gene	4137
37190913	757	760	tau	Gene	4137
37190913	775	780	Abeta	Gene	351
37190913	896	899	NTA	Chemical	MESH:D009571
37190913	900	903	tau	Gene	4137
37190913	939	942	tau	Gene	4137
37190913	971	974	NTA	Chemical	MESH:D009571
37190913	975	978	tau	Gene	4137
37190913	1012	1015	tau	Gene	4137
37190913	1054	1073	Alzheimer's disease	Disease	MESH:D000544
37190913	1075	1077	AD	Disease	MESH:D000544
37190913	1105	1108	tau	Gene	4137
37190913	1156	1159	tau	Gene	4137
37190913	1178	1180	AD	Disease	MESH:D000544
37190913	1214	1217	tau	Gene	4137
37190913	1329	1332	NTA	Chemical	MESH:D009571
37190913	1333	1336	tau	Gene	4137
37190913	1371	1374	NTA	Chemical	MESH:D009571
37190913	1375	1378	tau	Gene	4137
37190913	1411	1414	tau	Gene	4137
37190913	1424	1431	amyloid	Disease	MESH:C000718787
37190913	1439	1456	neurodegeneration	Disease	MESH:D019636
37190913	1458	1461	NTA	Chemical	MESH:D009571
37190913	1462	1465	tau	Gene	4137
37190913	1497	1500	tau	Gene	4137
37190913	1523	1525	AD	Disease	MESH:D000544
37190913	1544	1547	NTA	Chemical	MESH:D009571
37190913	1548	1551	tau	Gene	4137
37190913	1592	1600	impaired	Disease	MESH:D060825
37190913	1601	1613	amyloid-beta	Gene	351
37190913	Association	MESH:D019636	4137
37190913	Association	MESH:D055956	4137
37190913	Association	351	4137
37190913	Positive_Correlation	MESH:D009571	MESH:D060825
37190913	Association	MESH:D009571	MESH:D000544
37190913	Bind	MESH:D009571	4137
37190913	Association	MESH:D060825	4137
37190913	Positive_Correlation	MESH:D009571	351
37190913	Association	MESH:D000544	4137

